Mostrar el registro sencillo del ítem
dc.contributor.author | Galvez-Fernandez, Marta | |
dc.contributor.author | Rodriguez-Hernandez, Zulema | |
dc.contributor.author | Grau-Perez, Maria | |
dc.contributor.author | Chaves, F. Javier | |
dc.contributor.author | Garcia-Garcia, Ana Barbara | |
dc.contributor.author | Amigo, Nuria | |
dc.contributor.author | Monleon, Daniel | |
dc.contributor.author | Garcia-Barrera, Tamara | |
dc.contributor.author | Gomez-Ariza, Jose L. | |
dc.contributor.author | Briongos-Figuero, Laisa S. | |
dc.contributor.author | Perez-Castrillon, Jose L. | |
dc.contributor.author | Redon, Josep | |
dc.contributor.author | Tellez-Plaza, Maria | |
dc.contributor.author | Martin-Escudero, Juan C. | |
dc.date.accessioned | 2024-10-28T12:44:28Z | |
dc.date.available | 2024-10-28T12:44:28Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Free Radic Biol Med. 2023 Jan;194:52-61. | es |
dc.identifier.issn | 0891-5849 | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/70983 | |
dc.description.abstract | Background The potential joint influence of metabolites on bone fragility has been rarely evaluated. We assessed the association of plasma metabolic patterns with bone fragility endpoints (primarily, incident osteoporosis-related bone fractures, and, secondarily, bone mineral density BMD) in the Hortega Study participants. Redox balance plays a key role in bone metabolism. We also assessed differential associations in participant subgroups by redox-related metal exposure levels and candidate genetic variants. Material and methods In 467 participants older than 50 years from the Hortega Study, a representative sample from a region in Spain, we estimated metabolic principal components (mPC) for 54 plasma metabolites from NMR-spectrometry. Metals biomarkers were measured in plasma by AAS and in urine by HPLC-ICPMS. Redox-related SNPs (N = 341) were measured by oligo-ligation assay. Results The prospective association with incident bone fractures was inverse for mPC1 (non-essential and essential amino acids, including branched-chain, and bacterial co-metabolites, including isobutyrate, trimethylamines and phenylpropionate, versus fatty acids and VLDL) and mPC4 (HDL), but positive for mPC2 (essential amino acids, including aromatic, and bacterial co-metabolites, including isopropanol and methanol). Findings from BMD models were consistent. Participants with decreased selenium and increased antimony, arsenic and, suggestively, cadmium exposures showed higher mPC2-associated bone fractures risk. Genetic variants annotated to 19 genes, with the strongest evidence for NCF4, NOX4 and XDH, showed differential metabolic-related bone fractures risk. Conclusions Metabolic patterns reflecting amino acids, microbiota co-metabolism and lipid metabolism were associated with bone fragility endpoints. Carriers of redox-related variants may benefit from metabolic interventions to prevent the consequences of bone fragility depending on their antimony, arsenic, selenium, and, possibly, cadmium, exposure levels. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Elsevier | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.subject.classification | Metabolomics Bone mineral density Osteoporosis-related bone fractures Candidate genes Metals Redox | es |
dc.title | Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | 10.1016/j.freeradbiomed.2022.11.007 | es |
dc.identifier.publicationfirstpage | 52 | es |
dc.identifier.publicationlastpage | 61 | es |
dc.identifier.publicationtitle | Free Radical Biology and Medicine | es |
dc.identifier.publicationvolume | 194 | es |
dc.peerreviewed | SI | es |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |